Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of January 22, 2025, Lineage Cell Therapeutics (LCTX) has a market cap of $0.15 billion USD. According to our data, Lineage Cell Therapeutics is ranked No.7377 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Jan 22, 2025 | $0.15 B |
35.40%
|
| Dec 31, 2024 | $0.11 B |
-54.13%
|
| Dec 29, 2023 | $0.24 B |
-6.84%
|
| Dec 30, 2022 | $0.26 B |
-52.24%
|
| Dec 31, 2021 | $0.54 B |
39.20%
|
| Dec 31, 2020 | $0.39 B |
97.75%
|
| Dec 31, 2019 | $0.20 B |
-2.20%
|
| Dec 31, 2018 | $0.20 B |
-57.67%
|
| Dec 29, 2017 | $0.47 B |
-40.44%
|
| Dec 30, 2016 | $0.80 B |
-11.95%
|
| Dec 31, 2015 | $0.90 B |
9.92%
|
| Dec 31, 2014 | $0.82 B |
3.61%
|
| Dec 31, 2013 | $0.79 B |
14.65%
|
| Dec 31, 2012 | $0.69 B |
-45.96%
|
| Dec 30, 2011 | $1.28 B |
-30.25%
|
| Dec 31, 2010 | $1.84 B |
96.93%
|
| Dec 31, 2009 | $0.93 B |
138.98%
|
| Dec 31, 2008 | $0.39 B |
331.71%
|
| Dec 31, 2007 | $90.37 M |
51.85%
|
| Dec 29, 2006 | $59.51 M |
-12.90%
|
| Dec 30, 2005 | $68.33 M |
-79.47%
|
| Dec 31, 2004 | $0.33 B |
9.42%
|
| Dec 31, 2003 | $0.30 B |
-6.02%
|
| Dec 31, 2002 | $0.32 B |
-66.30%
|
| Dec 31, 2001 | $0.96 B |
-38.67%
|
| Dec 29, 2000 | $1.57 B |
-15.49%
|
| Dec 31, 1999 | $1.85 B |
-48.92%
|
| Dec 31, 1998 | $3.63 B |
-8.55%
|
| Dec 31, 1997 | $3.97 B |
103.57%
|
| Dec 31, 1996 | $1.95 B |
796.00%
|
| Dec 29, 1995 | $0.22 B |
56.25%
|
| Dec 30, 1994 | $0.14 B |
-74.60%
|
| Dec 31, 1993 | $0.55 B |
-19.23%
|
| Dec 31, 1992 | $0.68 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Mesoblast
MESO
|
$2.03 B |
0.000 M
|
Australia
|
 Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
 bluebird bio
BLUE
|
$77.49 M |
-0.000 M
|
USA
|
 Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
 Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
 Vericel
VCEL
|
$2.89 B |
0.000 M
|
USA
|
 Novavax
NVAX
|
$1.41 B |
-0.000 M
|
USA
|
 Curevac
CVAC
|
$0.89 B |
0.000 M
|
Germany
|
 Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
 Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
| Market Cap | = | LCTX Stock Price | * | LCTX Shares Outstanding |
| = | $0.68 | * | 0.22 B | |
| = | $0.15 B |